Design and molecular insights of drug-active metabolite based co-amorphous formulation: A case study of toltrazuril-ponazuril co-amorphous
- 15 January 2022
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 615, 121475
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Evolution of Supersaturation of Amorphous Pharmaceuticals: The Effect of Rate of Supersaturation GenerationMolecular Pharmaceutics, 2013
- Pharmacologically Active Drug Metabolites: Impact on Drug Discovery and PharmacotherapyPharmacological Reviews, 2013
- Polymer Templating of Supercooled Indomethacin for Polymorph SelectionACS Combinatorial Science, 2012
- Coamorphous Drug Systems: Enhanced Physical Stability and Dissolution Rate of Indomethacin and NaproxenMolecular Pharmaceutics, 2011
- Hansen solubility parameter as a tool to predict cocrystal formationInternational Journal of Pharmaceutics, 2011
- Characterization of Cimetidine–Piroxicam Coprecipitate Interaction Using Experimental Studies and Molecular Dynamic SimulationsAAPS PharmSciTech, 2010
- Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopyJournal of Pharmacy and Pharmacology, 2009
- Combined Use of Crystalline Salt Forms and Precipitation Inhibitors to Improve Oral Absorption of Celecoxib from Solid Oral FormulationsJournal of Pharmaceutical Sciences, 2007
- A study of amorphous molecular dispersions of indomethacin and its sodium saltJournal of Pharmaceutical Sciences, 2001
- Pharmaceutical Applications of PolymorphismJournal of Pharmaceutical Sciences, 1969